(Benzotriazol-1-yloxy)dipiperidinocarbenium hexafluorophosphate | CAS:190849-64-0

We serve (Benzotriazol-1-yloxy)dipiperidinocarbenium hexafluorophosphate CAS:190849-64-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(Benzotriazol-1-yloxy)dipiperidinocarbenium hexafluorophosphate

Chemical Name:(Benzotriazol-1-yloxy)dipiperidinocarbenium hexafluorophosphate
CAS.NO:190849-64-0
Synonyms:O-(Benzotriazol-1-yl)-N,N,N',N'-bis(pentamethylene;HBPipU
Molecular Formula:C17H24F6N5OP
Molecular Weight:459.37000
 
Physical and Chemical Properties:
Melting point:206oC;
 
Specification:
Appearance:Off-white to white crystalline powder
Purity(HPLC):≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As a condensation reagent
 



Contact us for information like (Benzotriazol-1-yloxy)dipiperidinocarbenium hexafluorophosphate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(Benzotriazol-1-yloxy)dipiperidinocarbenium hexafluorophosphate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(Benzotriazol-1-yloxy)dipiperidinocarbenium hexafluorophosphate Use and application,(Benzotriazol-1-yloxy)dipiperidinocarbenium hexafluorophosphate technical grade,usp/ep/jp grade.


Related News: Pharmaceutical intermediates and APIs belong to the fine chemical industry.2,2',4,4'-Tetrahydroxybenzophenone manufacturer We manufacture APIs and drug manufacturers make medicines from APIs.Methyl Valeraldehyde supplier The national airlines of Egypt, Qatar and Saudi Arabia have halted flights to and from China.Pentachlorobenzonitrile vendor Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.In order to seize the highest point of profits, international industry giants have adjusted their development strategies, concentrated their energies on the two ends of the smile curve-research and development and end products, and shifted production links such as intermediates and APIs outward. A division of labor model has been formed.